U.S. Craniomaxillofacial Devices Market Analysis Report By Material (Bioabsorbable, Metal), By Application, By Product (MF Plate, Temporomandibular Joint Replacement), And Segment Forecasts, 2018 - 2025

Industry Insights

The U.S. craniomaxillofacial devices market size was valued at 955.6 million in 2017. It is anticipated to register a CAGR of 6.9% during the forecast period. Increasing incidence of road accidents due to industrialization and urbanization has driven the market. According to the U.S. National Safety Council report, traffic deaths increased to 6.0% from 2015 to 2016. Total 40,200 accidents were reported in 2016 and the record was found to be the largest in more than half a century.

Surging demand for minimally invasive surgeries and growing incidence of facial fractures are estimated to fuel the demand for craniomaxillofacial devices in the coming years. Growing number of battlefield injuries and subsequently rising demand for associated CMF treatments are also expected to bode well for the market during the forecast period. According to a report by American Association Of Oral And Maxillofacial Surgeons, a total of 4,783 CMF battlefield injuries were reported in 2016.

Moreover, rising concerns regarding physical and aesthetic appearance among youth have been working in favor of the market. Benefits associated with these devices such as less recovery time, painless procedure, safety, efficacy, and less hospital stay are also likely to spur the growth of the market over the forecast period.

Furthermore, increasing incidence of facial deformities due to genetic disorders and trauma requiring cosmetic surgeries is impelling the demand for craniomaxillofacial implants. According to a report published by the American Society of Plastic Surgeons, the total number of minimally invasive cosmetic procedures was 13,945,388 in 2016. It is poised to grow by 4% every year. This represents the overall growth in CMF surgeries, which is projected to boost the demand for the product in the coming years. In addition, supportive insurance policies facilitating CMF surgeries such as Medicare are anticipated to bolster the growth of the market.

Product Insights

MF plate and screw fixation accounted for the largest revenue share in the market in 2017 owing to high adoption in different surgeries such as orthognathic, tumor removal, deformity correction, and cranial fixation. MF plates are widely used for cranial trauma, post-injury facial reconstruction, tumor removal, orthognathic procedures, pediatric procedures, and correction of deformities. According to a report by the American Society of Plastic Surgeons (ASPS), there were about 220,000 maxillofacial and craniofacial procedures performed in the country in 2016.

The temporomandibular joint (TMJ) replacement segment is estimated to register the fastest growth during the forecast period, owing to an increasing number of sports injuries and cranial fractures and spiraling demand for facial augmentation. It has various applications including arthritic conditions, fused joints, abnormalities, degenerated joints, and fractures. The devices also help in reducing jaw pain and interference with eating and increasing mouth opening capacity.

Material Insights

Metallic CMF implants were the most prominent material segment in the U.S. craniomaxillofacial devices market in 2017, owing to their advantages such as rigid properties, low corrosiveness, and cost-effectiveness as compared to bioabsorbable and ceramics materials. Stainless steel, titanium, vitallium, chromium, brass silver, and copper are some of the commonly used metals in internal rigid fixation of facial skeleton. Alloys of nickel, chromium, copper, cobalt, aluminum, and molybdenum stainless steel are used in the surgery. In 2016, FDA approved 3D printed titanium CMF implant manufactured by BioArchitects.

Bioabsorbable materials are expected to exhibit lucrative growth in the market as they can be easily assimilated by human body and negates the probability of second surgery. Technological advancements are also playing an important role in the growth of the segment. Rising popularity of SR technology and advantages associated with it such as easily handled, biocompatible, biodegradable and reliability has been positively influencing the growth of the overall market. Copolymeric SR devices such as PLGA, biosorb FX, and biosorb PDX are some technological advancements in clinical application of bioabsorbable materials.

Application Insights

Craniomaxillofacial devices found the largest application in neurosurgery in 2017, owing to rising CMF procedures in neurovascular surgery and oncological treatments. Neurosurgical applications of CMF devices consist of surgery of skull and otolaryngology procedures. These devices assist in treating neuro-oncology, spinal disorders, neurovascular diseases, nasal skull-based surgery, dura mater repair, deep brain stimulation, cranial trauma and, CSF management as well.

Plastic surgery is likely to witness a growth rate of 6.6% in the U.S. during the forecast period.The surgery is used to treat aesthetic skull problems such as sloped forehead, frontal bossing/ forehead horns, residual fontanelle depressions, sagittal ridge/crest, flat back of the head, occipital knob/protuberance, excessive temporal fullness (too wide of head), temporal depressions (too narrow of head), prominent temporal lines, and occipital asymmetries. According to a report by ASPS, total 15.9 million cosmetic surgeries were performed in the U.S. in 2015, which were 2.0% more than 2014.

U.S. Craniomaxillofacial Devices Market Share Insights

The market is marked by presence of various small and large companies. The market is competitive in nature. It is dominated by participants such as DePuy Synthes; Zimmer-Biomet Inc.; and Medtronic Inc.Companies are focusing on implementing strategies such as new product launch, regional expansion, partnership, and distribution agreements to increase their revenue share.

In September 2016, Medtronic received an FDA approval for its StealthStation cranial software for deep brain stimulation lead placement. Furthermore, in October 2017, Integra Lifesciences completed acquisition of Johnson & Johnson Codman neurosurgery business to expand its neurosurgical product portfolio. Furthermore, in April 2016, Stryker Corporation completed acquisition of Synergetics USA, Inc.'s Neuro Portfolio in a probe to gain more market share. In January 2014, Medartis AG launched Distal Ulna Plate for cranial fixation surgeries by implementing product expansion strategy to target the new market.

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at country level and provides an analysis of the industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the U.S. craniomaxillofacial devices market report on the basis of product, material, and application.

• Product Outlook (Revenue, USD Million, 2014 - 2025)

  • Cranial Flap Fixation

  • CMF Distraction

  • Temporomandibular joint replacement

  • Thoracic fixation

  • Bone Graft Substitute

  • MF plate and screw fixation

• Material Outlook (Revenue, USD Million, 2014 - 2025)

  • Metal

  • Bioabsorbable material

  • Ceramics

• Application Outlook (Revenue, USD Million, 2014 - 2025)

  • Neurosurgery

  • Orthognathic and Dental Surgery

  • Plastic surgery